KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsBuildingsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Boston Scientific (BSX) Finished Goods (2016 - 2025)

Boston Scientific (BSX) has disclosed Finished Goods for 17 consecutive years, with $1.8 billion as the latest value for Q4 2025.

  • Quarterly Finished Goods rose 2.84% to $1.8 billion in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $1.8 billion through Dec 2025, up 2.84% year-over-year, with the annual reading at $1.8 billion for FY2025, 2.84% up from the prior year.
  • Finished Goods hit $1.8 billion in Q4 2025 for Boston Scientific, up from $1.8 billion in the prior quarter.
  • In the past five years, Finished Goods ranged from a high of $1.8 billion in Q4 2025 to a low of $921.0 million in Q1 2021.
  • Historically, Finished Goods has averaged $1.4 billion across 5 years, with a median of $1.4 billion in 2023.
  • Biggest five-year swings in Finished Goods: fell 7.06% in 2021 and later soared 32.43% in 2023.
  • Year by year, Finished Goods stood at $1.0 billion in 2021, then rose by 13.8% to $1.2 billion in 2022, then soared by 31.26% to $1.5 billion in 2023, then increased by 16.98% to $1.8 billion in 2024, then grew by 2.84% to $1.8 billion in 2025.
  • Business Quant data shows Finished Goods for BSX at $1.8 billion in Q4 2025, $1.8 billion in Q3 2025, and $1.8 billion in Q2 2025.